Norris Medicines Ltd Share Price Today - Norris Medicines Ltd Stock Price Live NSE/BSE

Norris Medicines Ltd

NSE: BSE: 524414

₹15.60

(0%)

Tue, 25 Aug 2026, 07:37 am

MTF 5xInvest in Norris Medicines Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)0

PE Ratio0

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Norris Medicines Share Price Live Chart

1 Day

(0%)

No Result Found

Summary

Market Cap (in Cr)
13.25
Net Profit (in Cr)
-1.24
P/B
-1.12
Sector P/E
44.89
P/E
0
EV/EBITDA
0
Debt/Equity (Industry)
0.24
Interest Cover (Industry)
9.79
ROCE (Industry)
14.04
RONW (Industry)
13.17
ROE
0
ROCE
0
Debt/Equity
0
EPS (TTM)
0
Dividend Yield
0
Book Value
-15.82
Interest Cover
-1.68

Analysis

No Result Found

Financials

No Result Found

Ratios

No Result Found

Shareholders	MAR 2026	DEC 2025	SEPT 2025	JUN 2025	MAR 2025
Promoters	34.01	34.00	34.00	34.00	34.00
FII	0	0	0	0	0
DII	0.07	0.07	0.07	0.07	0.07
Public	65.92	65.93	65.93	65.93	65.93
Government	0	0	0	0	0

Technical Analysis

RSI

49.82

MACD

0.12

50 DMA

15.35

200 DMA

14.73

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	26.81	21.43	17.84	16.05	12.46	10.67	5.29
Fibonacci	21.43	19.37	18.10	16.05	13.99	12.72	10.67
Camarilla	15.74	15.25	14.75	16.05	13.77	13.27	12.78

Pivots Level: Classic

+10.76

26.81

+5.38

21.43

+1.80

17.84

16.05

Pivot Point

LTP: 15.50

-3.58

12.46

-5.38

10.67

-10.76

5.29

Moving Average

SMAEMA

Period

Value

10-EMA
15.68
20-EMA
15.58
30-EMA
15.49
50-EMA
15.29
100-EMA
14.98
200-EMA
15.11

Announcement Date	Purpose	Action
30 May 2026	board-meetings	Accounts
14 Feb 2026	board-meetings	Quarterly Results
14 Nov 2025	board-meetings	Quarterly Results
01 Sept 2025	agm
06 Sept 2024	agm
29 Dec 2023	egm
18 Nov 2023	agm
09 Sept 2022	agm
28 Aug 2021	agm

Peer Comparison

No Result Found

Norris Medicines Ltd

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd

Cipla Ltd

Divis Laboratories Ltd

Norris Medicines Ltd About

Norris Medicines manufactures generic pharmaceutical tablets, capsules, syrups, and suspension form products. The Company produces a range of antibiotic, anti-inflammatory, and analgesic products, as well as products for nutrition, anxiety, diabetes, and

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1990

Headquarters

CEO

Vimal D Shah

Employees

Contact

Website

http://www.norrispharma.com

norrismedicines@gmail.com; contact@norrispharma.co

Phone

91-2646-223462/227530

Location

Plot No 801/P & 802, GIDC Industrial Estate, Ankleshwar, Gujarat, 393002

Year	History
2000	The company issued 1,80,00,000 equity shares on a preferential/private placement basis to PHC Holdings Ltd. and Positive Healthcare (Asia) Ltd.
2006	The company launched diabetic and cardiac products.
2007	The company launched a dental product range.
2012	The company launched a new molecule Tolperisone with Paracetamol tablet.
2013	The company extended its anti-malarial range with Artemether Lumefantrine tablet and dry syrup.

Client Name	Deal Type	Order Side	QTY	Avg Price	Date
No Result Found

Norris Medicines Ltd News

Norris Medicines Appoints Iqubal Ismail Patel as CFO

Norris Medicines Limited has appointed Iqubal Ismail Patel as Chief Financial Officer and Key Managerial Personnel effective July 30, 2026. Patel brings over 11 years of internal experience in finance and corporate management to the role.

30 Jul 2026

companies

Norris Medicines board meeting on May 30

Norris Medicines Limited will hold a board meeting on May 30, 2026, to approve audited financial results for FY26. The trading window remains closed until 48 hours after the results declaration.

25 May 2026

companies

Norris Medicines Announces Q3 FY26 Results

Norris Medicines Limited's Board approved unaudited financial results for the quarter and year ended December 31, 2025, following their February 14, 2026 board meeting.

14 Feb 2026

co actions results

Norris Medicines Independent Director Resigns

Norris Medicines Limited announces resignation of Independent Director Ms. Sathya Venkatachalam effective December 12, 2025, citing personal reasons.

12 Dec 2025

stocks

Norris Medicines Clears NAFDAC Audit in Nigeria

Norris Medicines Limited successfully completed regulatory audit by Nigeria's National Agency for Food and Drug Administration and Control (NAFDAC) on December 9, 2025, with no critical observations reported.

12 Dec 2025

stocks

Norris Medicines Ltd

Norris Medicines Share Price Live Chart

Summary

Analysis

Financials

Ratios

Shareholding

Technical Analysis

Corporate Actions

Peer Comparison

Norris Medicines Ltd About

Contact

Norris Medicines Ltd Company History

Deals

Norris Medicines Ltd News